Inherited and acquired thrombophilia are associated with recurrent pregnancy loss (RPL).
We have evaluated the efficacy and safety of the low molecular weight heparin enoxaparin …

Scientific Frontiers in Developmental Toxicology and Risk Assessment reviews advances
made during the last 10-15 years in fields such as developmental biology, molecular …

This article discusses the management of venous thromboembolism (VTE) and
thrombophilia, as well as the use of antithrombotic agents, during pregnancy and is part of …

Objective: To assess the chromosomal aberrations in the abortus in recurrent miscarriage
and the live birth rate after a euploid or aneuploid miscarriage. Design: Retrospective …

Background Recurrent pregnancy loss (RPL) is a significant clinical problem. Recently,
thrombophilias have been implicated as a possible cause. Factor V Leiden (FVL) and …

Objective: To describe the characteristics of thrombophilia in women with idiopathic
pregnancy loss. Design: Prospective observational study. Setting: Tertiary referral center in a …

The myeloproliferative diseases (MPDs) present several therapeutic challenges in patients
of childbearing potential. The most extensive literature exists for patients with essential …

Introduction The aim of this study was to estimate the incidence of recurrent pregnancy loss
(RPL). The prevalence of RPL defined as three or more consecutive miscarriages before …

BACKGROUND Autoimmune diseases may selectively affect women in their reproductive
years, and conversely, pregnancy may affect the expression of autoimmune disease. This …

Recurrent pregnancy loss (RPL) affects 1% pregnancies and is multi‐factorial in origin. The
role of the acquired thrombophilia antiphospholipid syndrome (APS) as a common and …